Resources

Advocacy is a powerful tool for advancing health conversations to policy action and budget allocations. Since 2002, PATH has partnered with the Government of Uganda to implement impactful projects and programs that promote health equity. Our policy advocacy agenda in Uganda has been critical in supporting the adoption, implementation and financing of smart policies that advance the realization of universal health coverage in Uganda. In the second half of 2023, PATH’s advocacy and policy team in Uganda undertook an effort to comprehensively document its tremendous impact on policies for women and children over the past five years. Most of the policy advocacy achievements documented were a result of strong collaboration and partnerships with key decision-makers in government, including both elected and appointed leaders (political and technical), the media, the private sector, and the civil society organizations that continue to passionately advance the advocacy agenda with a strong focus on universal health coverage (UHC). The resources and videos below are the result of this process and were shared with PATH’s key stakeholders at a high-level national learning event.

PATH Kenya, through the U.S. President's Emergency Plan for AIDS Relief/U.S. Agency for International Development (USAID)-funded Nuru Ya Mtoto project, has been advancing a comprehensive suite of health, education, economic empowerment, and social services for orphans and vulnerable children (OVC) and their caretakers. The aim is to reduce vulnerability to HIV and contribute to their overall well-being.This brief provides an overview of the process USAID Nuru Ya Mtoto undertook, in collaboration with national and county government stakeholders, local implementing partners, and community health workers, to optimize and advance a whole-of-system suite of interventions to improve service coverage among OVC households and enhance household resiliency, by facilitating graduation from USAID Nuru Ya Mtoto's OVC program.

PATH helps policymakers and advocates make evidence-based policy and funding decisions to advance health equity. Leveraging PATH’s nearly 50 years of experience developing and delivering health innovations and services for women and children, PATH advocates collect, analyze, package, and use data to inform policies, mobilize resources, engage citizens, and hold decision-makers accountable to help women and children around the world survive and thrive.

Shigella is the leading bacterial cause of childhood diarrhea, and infections can have long-term effects on growth and development. No licensed Shigella vaccines currently exist, but several promising candidates in development could become available in a few years.PATH conducted a series of studies to better understand the public health value of potential Shigella vaccines and help inform decisions by international agencies, funders, vaccine developers, and national policymakers. This included: vaccine impact and cost-effectiveness analyses, demand forecasts for two potential markets, an expert consultation on Shigella-containing combination vaccines, and a feasibility and acceptability study with national stakeholders and healthcare providers in five countries. This brief provides a comprehensive summary of the results.

PATH helps policymakers and advocates make evidence-based policy and funding decisions to advance health equity. Leveraging PATH's nearly 50 years of experience developing and delivering health innovations and services for women and children, our advocates collect, analyze, package, and use data to inform policies, mobilize resources, engage citizens, and hold decision-makers accountable. This fact sheet details how PATH is driving change at the intersection of advocacy and technical assistance to help women and children around the world survive and thrive.